P

Prothena Corp
D

PRTA

6.44000
USD
0.12
(1.90%)
مغلق
حجم التداول
12,065
الربح لكل سهم
-3
العائد الربحي
-
P/E
-3
حجم السوق
346,645,764
أصول ذات صلة
ALNY
ALNY
-4.39
(-1.33%)
325.26 USD
AMGN
AMGN
1.79
(0.60%)
298.52 USD
C
CRSP
0.455
(0.88%)
52.120 USD
E
EDIT
0.02000
(0.78%)
2.57000 USD
GILD
GILD
-0.760
(-0.68%)
110.760 USD
ILMN
ILMN
0.360
(0.36%)
100.710 USD
N
NTLA
-0.020
(-0.19%)
10.710 USD
REGN
REGN
-0.69
(-0.13%)
546.88 USD
S
SGMO
0.00200
(0.38%)
0.53200 USD
المزيد
الأخبار المقالات

العنوان: Prothena Corp

القطاع: Healthcare
الصناعة: Biotechnology
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.